(Q44917204)

English

A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Jeffrey W Stephens

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Steven J Hurel

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jacqueline A Cooper

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jayshree Acharya

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

George J Miller

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Steve E Humphries

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

180-186

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Genetics of non-insulin-dependent (type-II) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Ramipril and the development of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Adipose tissue as an endocrine and paracrine organ

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

The interleukin 6-174G/C polymorphism is associated with indices of obesity in men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.001

7 January 2021

Identifiers

10.1016/J.YMGME.2004.04.001

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44917204&oldid=2056980453"